CCL4 and neoplasm: Recently, studies have shown that CD103+ CD11c+ DCs, a subpopulation of dermal- and gut-resident pAPCs, respond to tumor-derived CCL4 and are the chief cells that produce CXCL9 and CXCL10 to recruit tumor-infiltrating T cells (29, 30).